Grown Rogue International Inc. Stock OTC Markets
Stocks
GRUSF
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4291 USD | +1.90% |
|
-7.44% | -16.82% |
| 13/05 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 13/05 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 105M 90.91M 83.72M 78.6M 148M 9.97B 149M 989M 385M 4.88B 396M 388M 16.93B | P/E Ratio 2024 |
-12x | P/E Ratio 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 121M 104M 95.86M 90M 169M 11.42B 171M 1.13B 441M 5.59B 453M 444M 19.38B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | +1.90% | ||
| 1 week | -7.44% | ||
| Current month | +4.66% | ||
| 1 month | +16.00% | ||
| 3 months | +32.52% | ||
| 6 months | -2.03% | ||
| Current year | -16.82% |
| 1 week | 0.4 |  | 0.47 |
| 1 month | 0.35 | | 0.49 |
| Current year | 0.27 | | 0.52 |
| 1 year | 0.27 | | 0.52 |
| 3 years | 0.14 | | 0.9 |
| 5 years | 0.02 | | 0.9 |
| 10 years | 0 | | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 15/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.90% | -7.44% | - | - | 105M | |
| -1.48% | -0.18% | -12.55% | -7.49% | 13.22B | |
| -1.85% | -0.57% | -33.60% | -56.75% | 5.03B | |
| -2.20% | -2.30% | -10.97% | -3.17% | 4.66B | |
| -5.15% | +0.07% | +4.06% | -43.24% | 3.93B | |
| -1.39% | -0.70% | +13.04% | -16.03% | 3.89B | |
| -1.41% | -3.63% | -3.38% | -9.16% | 3.67B | |
| -2.20% | +1.57% | -11.35% | -2.47% | 3.21B | |
| +0.39% | +5.48% | -5.74% | -25.11% | 2.42B | |
| -1.48% | -4.26% | -12.56% | +27.12% | 1.75B | |
| Average | -1.49% | -1.29% | -8.12% | -15.14% | 4.64B | |
| Weighted average by Cap. | -1.87% | -1.40% | -9.67% | -16.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.28M 21.44M 20.13M 37.8M 2.55B 38.19M 253M 98.7M 1.25B 101M 99.24M 4.33B | 32.43M 27.95M 25.73M 24.16M 45.36M 3.07B 45.84M 304M 118M 1.5B 122M 119M 5.2B |
| Net income | -11.3M -9.74M -8.97M -8.42M -15.81M -1.07B -15.98M -106M -41.29M -523M -42.42M -41.52M -1.81B | 1.73M 1.49M 1.37M 1.29M 2.42M 164M 2.45M 16.22M 6.32M 80.09M 6.49M 6.35M 278M |
| Net Debt | 3.7M 3.19M 2.94M 2.76M 5.18M 350M 5.24M 34.74M 13.53M 172M 13.9M 13.61M 594M | 15.3M 13.19M 12.14M 11.4M 21.4M 1.45B 21.63M 143M 55.89M 708M 57.42M 56.2M 2.45B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/06/26 | 0.4291 $ | +1.90% | 45,050 |
| 15/06/26 | 0.4211 $ | -6.07% | 21,540 |
| 12/06/26 | 0.4483 $ | -3.59% | 67,786 |
| 11/06/26 | 0.4650 $ | +4.75% | 79,180 |
| 10/06/26 | 0.4439 $ | -4.25% | 37,565 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUSF Stock
Select your edition
All financial news and data tailored to specific country editions
